FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Find answers to all your questions on live ASTRAZEN message board: Is ASTRAZEN buy or sell? Should I buy ASTRAZEN shares? Why are ASTRAZEN shares falling? Should I invest in ASTRAZEN stock?

forum

ASTRAZEN Share Price Discussion

AstraZeneca Pharma India Ltd.
NSE: ASTRAZEN | BSE: 506820 | ISIN: INE203A01020 | Sector: Pharmaceuticals and health care
N
Reputation: 4,641 • May 18 2:08 AM
Trade Setup for Tuesday: Top 15 things to know before Opening Bell
Key support level for Nifty is placed at 8,700.57, followed by 8,577.88. If the index moves up, key resistance levels to watch out for are 9,052.12 and 9,280.98.
Moneycontrol
Like
Reply
NSE:ASTRAZEN price when posted: 3,048
Recent posts in ASTRAZEN
N
Reputation: 4,641 • Today 6:36 AM
Wockhardt surges 10% on signing Covid-19 deal with UK government
As per the terms of the agreement, Wockhardt has reserved manufacturing capacity to allow for the supply of multiple vaccines to the UK government.
The Economic Times
Like
Reply
N
Reputation: 4,641 • Yesterday 8:51 AM
Wockhardt Ltd to make COVID-19 vaccines for United Kingdom
The company has reserved manufacturing capacity to supply vaccines to the UK, including the one being developed by AstraZeneca and Oxford University, as part of an agreement with the UK government, it added.
The Economic Times
Like
Reply
N
Reputation: 4,641 • Yesterday 3:31 AM
Pricing Covid-19 vaccines too high could backfire on big pharmaceutical companies
A world without global intellectual property would be one of constant electronic warfare. State-backed hacking, such as China apparently tried with Moderna this week, would be a constant threat. Nor would companies enjoy a comfortable relationship with their own governments, who would see them less as engines of growth and more as storehouses of national wealth.
The Economic Times
Like
Reply
N
Reputation: 4,641 • Aug 2 6:41 AM
When it comes to a coronavirus vaccine, rich nations are first in line
Although international groups and a number of nations are promising to make vaccines affordable and accessible to all, doses will likely struggle to keep up with demand in a world of roughly 7.8 billion people. The possibility wealthier countries will monopolize supply, a scenario that played out in the 2009 swine flu pandemic, has fueled concerns among poor nations and health advocates.
The Economic Times
Like
Reply
N
Reputation: 4,641 • Aug 2 3:16 AM
With trials just starting, Adar Poonawalla gets a front-row seat to the global vaccine race
The Serum Institute, which is exclusively controlled by a small and fabulously rich Indian family and started out years ago as a horse farm, is doing what a few other companies in the race for a vaccine are doing: mass-producing hundreds of millions of doses of a vaccine candidate that is still in trials and might not even work.
The Economic Times
Like
Reply
N
Reputation: 4,641 • Aug 1 12:11 PM
Serum Institute of India gets approval to start human trials for Oxford vaccine
Earlier this week, a committee of experts had deferred a decision on the request of SII to start trials and asked the company to amend its protocol for the clinical study. The subject expert committee (SEC) had recommended eight amendments to be made to the firm's proposal to conduct Phase-II and -III trials.
The Economic Times
Like
Reply